Sanara MedTech Inc.
SMTI
$20.76
$0.391.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.51% | 28.14% | 26.42% | 48.70% | 35.24% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.51% | 28.14% | 26.42% | 48.70% | 35.24% |
| Cost of Revenue | -5.91% | -3.55% | -2.91% | 25.78% | 13.74% |
| Gross Profit | 24.29% | 31.64% | 29.75% | 51.28% | 37.87% |
| SG&A Expenses | 14.11% | 13.69% | 32.41% | 34.02% | 25.53% |
| Depreciation & Amortization | -12.34% | 0.79% | 1.72% | 0.62% | -30.15% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.96% | 12.16% | 26.72% | 39.18% | 18.62% |
| Operating Income | 277.80% | 98.92% | -30.21% | 38.03% | 149.01% |
| Income Before Tax | 562.33% | 42.81% | -96.08% | -548.09% | 83.51% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 562.33% | 42.81% | -96.08% | -548.09% | 83.51% |
| Earnings from Discontinued Operations | -1,066.35% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -41.18% | -84.13% | -99.43% | 540.32% | -95.09% |
| Net Income | -964.15% | 42.51% | -99.93% | -548.65% | -169.50% |
| EBIT | 277.80% | 98.92% | -30.21% | 38.03% | 149.01% |
| EBITDA | 91.55% | 160.39% | -94.23% | 76.99% | 418.67% |
| EPS Basic | -948.32% | 43.48% | -96.47% | -537.10% | -163.55% |
| Normalized Basic EPS | 564.62% | 43.52% | -92.03% | 2.15% | 89.93% |
| EPS Diluted | -914.87% | 43.48% | -96.47% | -537.10% | -163.55% |
| Normalized Diluted EPS | 549.23% | 43.52% | -92.03% | 2.15% | 89.93% |
| Average Basic Shares Outstanding | 1.52% | 1.70% | 1.79% | 1.78% | 2.22% |
| Average Diluted Shares Outstanding | 4.97% | 1.70% | 1.79% | 1.78% | 2.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |